Cascadian Therapeutics, Inc. CASC
No live quote for CASC yet.
No chart data for this range yet.
- Volume
- 2.00K
- Open
- 10.00
- Previous close
- 10.02
Fundamental scorecard
7 of 25 checks passed on CASC’s reported financials
7of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Dec 31, 2017; valued at the market value on the latest filing.
Financials — quick view
CASC Revenue — quarterly 0
CASC Net income — quarterly -16.76M
CASC EPS — quarterly -0.34
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 6, 2017 | Barclays | init | — | Underweight |
| Apr 20, 2017 | BTIG Research | init | — | Buy |
| Feb 21, 2012 | Global Hunter Securities | down | — | Accumulate |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CASC — it syncs with the Stock Master app.
